SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

SIE

209.2

-0.19%↓

AIR.FR

164.7

-0.6%↓

ENR.DE

150.5

+1.93%↑

RHM

1,458

-1.22%↓

HO

240.3

+0.29%↑

Search

SPIE SA.

Închisă

SectorSectorul industrial

44.04 -1.08

Rezumat

Modificarea prețului

24h

Curent

Minim

43.5

Maxim

44.5

Indicatori cheie

By Trading Economics

Venit

203M

190M

Vânzări

350M

5.4B

P/E

Medie Sector

44.519

61.065

Randament dividend

2.34

Marjă de profit

3.512

Angajați

54,673

EBITDA

317M

629M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+24.6% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

2.34%

2.23%

Statistici piață

By TradingEconomics

Capitalizare de piață

-987M

7.9B

Deschiderea anterioară

45.12

Închiderea anterioară

44.04

Sentimentul știrilor

By Acuity

70%

30%

379 / 406 Clasament în Industrials

Scor tehnic

By Trading Central

Încredere

Weak Bullish Evidence

SPIE SA. Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 mar. 2026, 23:47 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar. 2026, 22:55 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar. 2026, 21:51 UTC

Achiziții, Fuziuni, Preluări

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar. 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 mar. 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar. 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar. 2026, 22:42 UTC

Market Talk
Evenimente importante

Global Equities Roundup: Market Talk

23 mar. 2026, 22:42 UTC

Market Talk
Evenimente importante

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar. 2026, 22:40 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar. 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar. 2026, 22:22 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar. 2026, 22:21 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar. 2026, 22:21 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar. 2026, 22:20 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar. 2026, 22:20 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar. 2026, 22:19 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar. 2026, 22:19 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar. 2026, 22:18 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar. 2026, 22:15 UTC

Achiziții, Fuziuni, Preluări

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar. 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar. 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 mar. 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar. 2026, 21:32 UTC

Câștiguri

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar. 2026, 21:10 UTC

Evenimente importante

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 mar. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 mar. 2026, 20:50 UTC

Market Talk
Câștiguri
Evenimente importante

Basic Materials Roundup: Market Talk

Comparație

Modificare preț

SPIE SA. Așteptări

Obiectiv de preț

By TipRanks

24.6% sus

Prognoză pe 12 luni

Medie 54 EUR  24.6%

Maxim 57 EUR

Minim 51 EUR

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruSPIE SA. - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

1

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

43.14 / 43.96Suport & Rezistență

Termen scurt

Weak Bullish Evidence

Termen mediu

Bullish Evidence

Termen lung

Bullish Evidence

Sentiment

By Acuity

379 / 406 Clasament în Sectorul industrial

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre SPIE SA.

SPIE SA provides multi-technical services in the areas of energy and communications in France, Germany, the Netherlands, and internationally. The company operates through four segments: France; Germany and Central Europe; North-Western Europe; and Oil & Gas and Nuclear. It provides building modelling and design services; IT maintenance and managed services; information and communications technology engineering and consulting services; technical facility management, energy-efficiency, and technical services for the transmission and distribution of energy for industrial clients, as well as in the areas of electrical and security, HVAC, and information and communications technology; and electrical, mechanical, and HVAC engineering services. The company also offers building information modelling, building management systems, augmented reality, IoT and data management, and smart maintenance services; oil and gas services; construction, renovation, and maintenance services for bridges, locks, and pumping stations; maintenance and innovative solutions for traffic infrastructure; and fixed and mobile digital telecom networks, as well as technical building management, communications and networks, and tech FM services; engineering, construction, maintenance, and optimization services for industrial processes; energy recovery and sustainable management services to technical facilities; and energy transmission networks, medium-voltage facilities, distribution networks, busbar systems, and wind and solar power farms. In addition, it engages in the analysis of site conditions; planning, installation, and commissioning of technology; mechanical and industrial robotic solutions; and provision of electric solutions comprising lighting, street lighting, safety and security, prefabrication, and signage solutions. SPIE SA was founded in 1900 and is headquartered in Cergy-Pontoise, France.
help-icon Live chat